Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ranitidine hydrochloride, quantity: 168 mg (equivalent: ranitidine, qty 150 mg) - tablet, dispersible - excipient ingredients: magnesium stearate; croscarmellose sodium; microcrystalline cellulose; hyprolose; titanium dioxide; saccharin sodium; hypromellose; flavour - 1. short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. treatment of gastrinoma (zollinger-ellison syndrome). 5. short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. treatment of scleroderma oesphagitis. the intravenous injection is indicated where oral treatment is inappropriate

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - ranitidine hydrochloride - syrup - 150 mg/10ml - h2-receptor antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - ranitidine hydrochloride - film coated tablet - 300 mg - h2-receptor antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - ranitidine hydrochloride - film coated tablet - 150 mg - h2-receptor antagonists

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - ranitidine - solution for infusion or injection - ranitidine 25 mg/ml - drugs for acid related disorders

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ranitidine - solution for injection/infusion - 25 milligram(s)/millilitre - h2-receptor antagonists; ranitidine

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ranitidine hydrochloride - effervescent tablet - 150 milligram(s) - h2-receptor antagonists; ranitidine

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ranitidine hydrochloride - syrup - 150 milligram/ 10 millilitre - h2-receptor antagonists; ranitidine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - ranitidine hydrochloride - solution for injection - 25mg/1ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - ranitidine hydrochloride -